World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030

NewsGuard 100/100 Score

July 28th is marked as world hepatitis day. The world is united in elimination of viral hepatitis by 2030. The World Health Organization (WHO) has published new data from 28 countries today and shown that nearly 70% of the world hepatitis burden is borne by these countries.

However national campaigns are in place and there is a momentum towards elimination of viral hepatitis. The report states that 86% of the countries that have been studied have a campaign in place along with hepatitis elimination targets.

Over 70% of the countries have started to develop a national hepatitis plan in order to start effective prevention of the disease and also early and effective diagnosis, treatment and care. Universal access to hepatitis treatment is also started by nearly half of the countries.

World Hepatitis Day
World Hepatitis Day. Image Credit: awsome design studio / Shutterstock

The report goes on to estimate that there are still 1.34 million deaths each year due to viral hepatitis and these numbers have risen by 22% since 2000. A World Hepatitis Alliance thus is set up and the member states are being urged to speed up diagnosis and early treatment efforts for hepatitis B and C.

According to Raquel Peck, CEO of the World Hepatitis Alliance, who is herself a hepatitis C survivor who is now cured, it is no longer a dream to eliminate hepatitis but targets seem achievable. Peck called forth countries and governments on World Hepatitis Day to “collaborate, identify and overcome the significant barriers” that are still present. Peck reminded the increasing number of hepatitis related deaths and urged for efficient testing and early treatment in all parts of the world.

The first-ever Global Hepatitis Report by the World Health Organization (WHO) was published this year. This was the baseline data that can measure the progress which would be made till 2030 in eliminating hepatitis B and C. Till date no baseline data on hepatitis was available in such a concrete and comprehensive manner.

World Hepatitis Day 2017 with this baseline data can now call for multi-stakeholder collaboration to move towards hepatitis elimination. The baseline data has shown that one of the easier targets in complete hepatitis immunization or vaccination for children.

Other relatively easier targets are eliminating mother-to-child transmissions. Peck said everyone is at risk of developing hepatitis and the whole community needs to come forth towards these efforts.

This year, the World Hepatitis Day campaign recognized by WHO, has asked people to show their face as support in a selfie using #ShowYourFace. This is to be posted along with a message of support towards the elimination goals. Peck said that the public is being asked to show their faces “in solidarity of the 325 million people living with viral hepatitis”.

Viral Hepatitis

Hepatitis B is a viral infection of the liver that is spread when contact is made with blood or blood products from an infected individual. Hepatitis B can be transmitted through contact with blood and bodily fluids and the following can therefore lead to infection:

  • Blood transfusion with contaminated blood
  • Unprotected sex, including anal and oral sex
  • Sharing of infected needles between drug users
  • During birth, from an infected mother to the baby

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection. Hepatitis C infection is acquired by blood borne methods. Persons with the infection carry the virus in their blood and body fluids. Exchange of these body fluids with a healthy person leads to transmission of the infection.

The hepatitis C virus may be transmitted via blood transfusion, through exchange of saliva and semen or vaginal fluid of an infected person. It is most commonly spread via blood since the virus is concentrated in blood. Injection drug abusers are most commonly at risk of contracting the infection because they often share equipment.

According to the WHO estimated 325 million people were living with chronic hepatitis infections (HBV or HCV) worldwide in 2015.

Globally, 1.34 million people died of viral in 2015 and over 95% of people with hepatitis C can be completely cured within 2-3 months.

References

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20170727/World-Hepatitis-Day-gearing-towards-eliminating-viral-hepatitis-by-2030.aspx.

  • MLA

    Mandal, Ananya. "World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20170727/World-Hepatitis-Day-gearing-towards-eliminating-viral-hepatitis-by-2030.aspx>.

  • Chicago

    Mandal, Ananya. "World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030". News-Medical. https://www.news-medical.net/news/20170727/World-Hepatitis-Day-gearing-towards-eliminating-viral-hepatitis-by-2030.aspx. (accessed April 25, 2024).

  • Harvard

    Mandal, Ananya. 2018. World Hepatitis Day – gearing towards eliminating viral hepatitis by 2030. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20170727/World-Hepatitis-Day-gearing-towards-eliminating-viral-hepatitis-by-2030.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Paxlovid enhances treatment options for COVID-19 patients